North America Pharmaceutical Manufacturing Market Size & Outlook
North America pharmaceutical manufacturing market, 2018-2030 (US$M)
Related Markets
North America pharmaceutical manufacturing market highlights
- The North America pharmaceutical manufacturing market generated a revenue of USD 207,906.1 million in 2023.
- The market is expected to grow at a CAGR of 8% from 2024 to 2030.
- In terms of segment, conventional drugs (small molecules) was the largest revenue generating molecule type in 2023.
- Conventional Drugs (Small Molecules) is the most lucrative molecule type segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 207,906.1 million |
| Market revenue in 2030 | USD 355,588.4 million |
| Growth rate | 8% (CAGR from 2023 to 2030) |
| Largest segment | Conventional drugs (small molecules) |
| Fastest growing segment | Conventional Drugs (Small Molecules) |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Biologics & Biosimilars (Large Molecules), Conventional Drugs (Small Molecules) |
| Key market players worldwide | Roche Holding AG ADR, Novartis AG ADR, GlaxoSmithKline, Pfizer Inc, Merck & Co Inc, AstraZeneca PLC, Johnson & Johnson, Sanofi SA, Eli Lilly and Co, AbbVie Inc, Thermo Fisher Scientific Inc, Wuxi AppTec Co Ltd, Samsung BioLogics, FUJIFILM Holdings Corp, Lonza Group Ltd, Catalent Inc, Jubilant Pharmova |
Other key industry trends
- In terms of revenue, North America region accounted for 41.3% of the global pharmaceutical manufacturing market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 207,213.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Pharmaceutical Manufacturing Market Scope
Pharmaceutical Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America pharmaceutical manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical manufacturing market will help companies and investors design strategic landscapes.
Conventional drugs (small molecules) was the largest segment with a revenue share of 52.03% in 2023. Horizon Databook has segmented the North America pharmaceutical manufacturing market based on biologics & biosimilars (large molecules), conventional drugs (small molecules) covering the revenue growth of each sub-segment from 2018 to 2030.
In 2022, North America held the largest share of 37.01% of the pharmaceutical manufacturing market. Growth in the region can be attributed to the rising prevalence of chronic diseases and favorable government initiatives.
North America is a developed region with high healthcare expenditure. The local presence of regulatory entities in North America is expected to boost the pharmaceutical manufacturing market. Growth in the region is further supported by these entities playing a vital role in creating awareness among people about the potential therapies in disease management.
Moreover, the high prevalence of eye diseases and increasing eye treatment procedures are contributing to market growth in North America. High healthcare costs are among the primary factors driving market growth, boosting the demand for fast-acting and high-efficacy drugs.
Reasons to subscribe to North America pharmaceutical manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America pharmaceutical manufacturing market databook
-
Our clientele includes a mix of pharmaceutical manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America pharmaceutical manufacturing market , including forecasts for subscribers. This continent databook contains high-level insights into North America pharmaceutical manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America pharmaceutical manufacturing market size, by country, 2018-2030 (US$M)
North America Pharmaceutical Manufacturing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
